NBIX PEER ANALYSIS

Neurocrine Biosciences Inc — metric-by-metric comparison with peers and the industry median

NBIXNeurocrine Biosciences Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

NBIXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	NBIX	MRK	ROVI	BHC	ECILC	GENIL	Ind. Median
P/E	27.45	24.33	22.12●	—	—	46.82	21.55
P/B	5.39	2.07	4.33	-0.89●	0.77	3.47	1.91
EV/EBITDA	18.25	11.70	14.66	4.05●	32.83	14.07	12.18
P/S	5.92	2.94	3.93	0.21●	4.88	1.86	2.13

Financial Health
Metric	NBIX	MRK	ROVI	BHC	ECILC	GENIL	Ind. Median
Current Ratio	2.93	1.51	3.66●	1.32	1.73	1.33	2.22
Debt/Equity	11.9%	40.5%	17.0%	-1,010.0%●	5.9%	41.0%	46.3%
NetDebt/EBITDA	-0.95●	1.38	0.09	3.71	-0.10	1.10	1.24

Profitability
Metric	NBIX	MRK	ROVI	BHC	ECILC	GENIL	Ind. Median
Net Margin	21.6%●	12.1%	17.8%	-13.5%	-3.6%	4.0%	4.0%
ROE	22.5%●	8.5%	20.9%	—	-0.6%	8.7%	6.4%
ROA	15.6%●	4.9%	15.1%	-4.7%	-0.5%	4.8%	3.4%
EBITDA Margin	30.8%	28.5%	27.0%	60.0%●	14.8%	14.3%	18.2%

Growth + Dividend
Metric	NBIX	MRK	ROVI	BHC	ECILC	GENIL	Ind. Median
Rev. Growth	28.6%●	-1.7%	-3.4%	-9.9%	-2.3%	16.3%	7.5%
NI Growth	118.6%	-10.1%	-5.9%	—	—	146.6%●	5.0%
Div. Yield	—	1.5%	1.6%	0.0%	2.7%●	0.0%	2.0%
Payout	—	11.8%	36.3%	0.0%	-365.1%	0.0%	0.8%

Valuation
Metric	NBIX	VTRS	ELAN	UTHR	ZTS	ALKS	Ind. Median
P/E	27.45	—	—	20.67	12.19●	60.09	21.55
P/B	5.39	1.36●	1.92	4.51	9.97	5.24	1.91
EV/EBITDA	18.25	12.66	20.98	—	9.81●	37.08	12.18
P/S	5.92	1.37●	2.55	8.39	3.39	5.87	2.13

Financial Health
Metric	NBIX	VTRS	ELAN	UTHR	ZTS	ALKS	Ind. Median
Current Ratio	2.93	1.60	2.16	4.79●	3.15	2.27	2.22
Debt/Equity	11.9%●	97.9%	61.4%	—	285.7%	90.3%	46.3%
NetDebt/EBITDA	-0.95●	4.89	4.66	—	1.81	3.87	1.24

Profitability
Metric	NBIX	VTRS	ELAN	UTHR	ZTS	ALKS	Ind. Median
Net Margin	21.6%	-2.0%	-4.9%	40.6%●	27.8%	9.8%	4.0%
ROE	22.5%	-2.0%	-3.8%	20.3%	67.0%●	9.4%	6.4%
ROA	15.6%	-0.8%	-1.8%	17.8%	18.1%●	4.8%	3.4%
EBITDA Margin	30.8%	17.6%	15.6%	54.1%●	42.4%	17.7%	18.2%

Growth + Dividend
Metric	NBIX	VTRS	ELAN	UTHR	ZTS	ALKS	Ind. Median
Rev. Growth	28.6%●	1.6%	10.5%	5.9%	2.4%	3.2%	7.5%
NI Growth	118.6%●	—	—	6.3%	5.0%	-56.7%	5.0%
Div. Yield	—	3.0%●	—	—	2.8%	—	2.0%
Payout	—	-188.0%	—	—	33.6%	—	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on NBIX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.